CA999578A - 14-hydroxymorphinan derivatives - Google Patents

14-hydroxymorphinan derivatives

Info

Publication number
CA999578A
CA999578A CA150,036A CA150036A CA999578A CA 999578 A CA999578 A CA 999578A CA 150036 A CA150036 A CA 150036A CA 999578 A CA999578 A CA 999578A
Authority
CA
Canada
Prior art keywords
hydroxymorphinan derivatives
hydroxymorphinan
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA150,036A
Other languages
English (en)
Other versions
CA150036S (en
Inventor
Irwin J. Pachter
Bernard R. Belleau
Ivo Monkovic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Canada Inc
Original Assignee
Bristol Myers Canada Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Canada Ltd filed Critical Bristol Myers Canada Ltd
Application granted granted Critical
Publication of CA999578A publication Critical patent/CA999578A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/36—Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/28—Morphinans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/26—Phenanthrenes; Hydrogenated phenanthrenes
CA150,036A 1971-09-08 1972-08-23 14-hydroxymorphinan derivatives Expired CA999578A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17883771A 1971-09-08 1971-09-08
US00217633A US3819635A (en) 1971-09-08 1972-01-13 14-hydroxymorphinan derivatives

Publications (1)

Publication Number Publication Date
CA999578A true CA999578A (en) 1976-11-09

Family

ID=26874723

Family Applications (1)

Application Number Title Priority Date Filing Date
CA150,036A Expired CA999578A (en) 1971-09-08 1972-08-23 14-hydroxymorphinan derivatives

Country Status (19)

Country Link
US (1) US3819635A (fr)
JP (1) JPS5310596B2 (fr)
AU (1) AU470102B2 (fr)
BE (1) BE788478A (fr)
CA (1) CA999578A (fr)
CH (1) CH590845A5 (fr)
CY (1) CY980A (fr)
DD (1) DD100255A5 (fr)
DE (3) DE2265256C2 (fr)
DK (1) DK141624B (fr)
FR (1) FR2154481B1 (fr)
GB (2) GB1412129A (fr)
HK (1) HK2679A (fr)
IE (2) IE36687B1 (fr)
KE (1) KE2911A (fr)
MY (1) MY7900027A (fr)
NL (1) NL162072C (fr)
SE (2) SE398877B (fr)
YU (1) YU45099B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910920A (en) * 1973-11-07 1975-10-07 Bristol Myers Co 3,14,17-Substituted-6,7-tetramethylenemorphinans
US3980641A (en) * 1975-07-31 1976-09-14 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinans
US4017497A (en) * 1975-11-18 1977-04-12 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinan derivatives
US4139534A (en) * 1977-02-17 1979-02-13 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinan derivatives
JPS52136176A (en) * 1976-03-23 1977-11-14 Bristol Myers Co Method of improving 144hydroxymorphinan derivatives
US4058531A (en) * 1976-03-23 1977-11-15 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinan derivatives
US4052389A (en) * 1976-03-23 1977-10-04 Bristol-Myers Company Derivatives of 9,10-dihydroxy-1-(p-alkoxybenzyl)-perhydroisoquinoline oxazine-3-one
GB1593191A (en) * 1977-03-23 1981-07-15 Reckitt & Colmann Prod Ltd Derivatives of morphine
GB1587831A (en) * 1977-03-23 1981-04-08 Reckitt & Colmann Prod Ltd Morphine derivatives
US4115389A (en) * 1977-05-02 1978-09-19 Bristol-Myers Company Process of N-demethylating (-)-1-(p-methoxybenzyl)-2-methyl-1,2,3,4,5,6,7,8-octahydroisoquinoline
US4338320A (en) * 1978-11-15 1982-07-06 The Board Of Regents Of The University Of Nebraska Esters of 6'-hydroxycinchonine, and a method of treating arrythmia with them
US4228285A (en) * 1979-02-28 1980-10-14 Bristol-Myers Company 14-Hydroxy-6-oxamorphinans and 14-hydroxy-6-oxaisomorphinans
US4272540A (en) * 1979-04-24 1981-06-09 Sisa, Incorporated 14-Methoxymorphinan-6-one compounds and therapeutic methods of treating pain and drug dependence with them
US4322427A (en) * 1981-04-16 1982-03-30 Bristol-Myers Company Analgetic compositions and methods of use
EP0661283B1 (fr) * 1993-07-19 1998-10-21 Toray Industries, Inc. Agent de protection de cellules cerebrales
NZ268969A (en) * 1993-07-23 1997-06-24 Toray Industries Morphinan derivatives and pharmaceutical compositions
CZ281174B6 (cs) * 1993-08-13 1996-07-17 Galena, A.S. Způsob přípravy 3,14ß-dihydroxy-17-normorfinanu
AU753278B2 (en) 1998-02-25 2002-10-10 Abbott Laboratories Butorphanol sustained release formulations
US20040167164A1 (en) * 1998-05-05 2004-08-26 Jose Pozuelo Compositions and methods for treating particular chemical addictions and mental illnesses
EP2987788A1 (fr) 2002-05-17 2016-02-24 Taiwanj Pharmaceuticals Co., Ltd. Composés opioïdes et de type opioïde et leurs utilisations
US7923454B2 (en) 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7501433B2 (en) * 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US8017622B2 (en) * 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
CN103073496B (zh) * 2013-02-18 2015-08-26 苏州立新制药有限公司 右美沙芬的制备方法
ES2750853T3 (es) 2014-10-14 2020-03-27 Hisamitsu Pharmaceutical Co Parche adhesivo

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3166559A (en) * 1965-01-19 J-lower alkoxy-x-phenyloxy-ix-hydroxy-
GB1028407A (en) * 1962-04-06 1966-05-04 Shionogi & Co Improvements in or relating to morphinan derivatives and their preparation
FR1362540A (fr) * 1963-04-05 1964-06-05 Shionogi & Co Dérivés n substitués du morphinane et leur production

Also Published As

Publication number Publication date
GB1412129A (en) 1975-10-29
DE2265256C2 (de) 1985-10-24
DK141624B (da) 1980-05-12
FR2154481A1 (fr) 1973-05-11
DE2265255C2 (de) 1986-06-05
IE36687L (en) 1973-03-08
US3819635A (en) 1974-06-25
HK2679A (en) 1979-01-19
NL162072B (nl) 1979-11-15
JPS4834864A (fr) 1973-05-22
YU227772A (en) 1982-02-28
MY7900027A (en) 1979-12-31
NL7212176A (fr) 1973-03-12
DK141624C (fr) 1980-10-13
IE36688B1 (en) 1977-02-02
YU45099B (sh) 1992-07-20
AU470102B2 (en) 1976-03-04
JPS5310596B2 (fr) 1978-04-14
DE2265256A1 (de) 1977-01-27
SE398877B (sv) 1978-01-23
SE7506292L (sv) 1975-06-02
AU4622872A (en) 1974-03-07
DE2243961C2 (fr) 1988-07-21
CY980A (en) 1979-03-23
SE403286B (sv) 1978-08-07
DE2243961A1 (de) 1973-04-05
KE2911A (en) 1979-01-26
NL162072C (nl) 1980-04-15
CH590845A5 (fr) 1977-08-31
BE788478A (fr) 1973-03-06
GB1412130A (en) 1975-10-29
DD100255A5 (fr) 1973-09-12
IE36687B1 (en) 1977-02-02
FR2154481B1 (fr) 1976-04-23
DE2265255A1 (de) 1977-01-27

Similar Documents

Publication Publication Date Title
CA999578A (en) 14-hydroxymorphinan derivatives
AU468250B2 (en) 3-nitropyrazole derivatives
AU462723B2 (en) 2-nitro-5-imidazolyaldehyde derivatives
AU461957B2 (en) Lumilysergol derivatives
CA1017335A (en) Triazolyl-ethenyl-phenylene derivatives
AU463679B2 (en) Dibenzocycloheptadioxolan derivatives
AU470552B2 (en) Aminocephalosporin derivatives
AU472069B2 (en) Dibenzoxirenazepine derivatives
CA867769A (en) Fluoracylamino-trichloromethyl-methane derivatives
CA866804A (en) Spiro-azatetramethylene derivatives
CA872252A (en) 4-substituted-benzocyclohepta-imidazole derivatives
AU458249B2 (en) Tropan-3-ol derivatives
AU450164B2 (en) Thienobenzothiazepine derivatives
CA868361A (en) Thieno-benzothiazine derivatives
AU463550B2 (en) Nitrofurylpyrimidine derivatives
CA887666A (en) 3-keto-4-methylenecyclohexane derivatives
CA887665A (en) 3-hydroperoxy-4-methylenecyclohexane derivatives
CA883830A (en) Dichloro-2-oxopolymethylenimines derivatives
CA882122A (en) 3-halo-iminodibenzyl derivatives
CA880321A (en) Tropanol derivatives
CA879692A (en) Benzazocine derivatives
CA879103A (en) 3-amino-propoxy-indole derivatives
CA874996A (en) Diaryloxalamide derivatives
CA873890A (en) 5-nitrofuran derivatives
CA872805A (en) 3-aryloxyalkylpiperidine derivatives